A life-sciences R and D strategy allocates scarce R and D capital across a portfolio of programmes to maximise risk-adjusted value, using disciplined stage-gate governance. This is the Life Sciences R and D Strategy from the Stratenity Library, a governed strategic execution asset that is already built for you. It gives your team the full working method for life sciences r and d strategy, and it walks through everything from target and pipeline strategy to external innovation and partnerships. Every asset ships with a worked client example, a clear RACI, defined KPIs, and governance you can defend, so your team adapts it to a live client engagement instead of starting from a blank page.
What this asset covers
This is a preview of the full deliverable. Inside the Stratenity Library, this asset walks your team through the complete method, section by section, with a worked client example threaded throughout.
- The R and D Productivity Challenge
- Portfolio Strategy and Prioritisation
- Target and Pipeline Strategy
- Clinical Development Design
- The R and D Operating Model
- Data, AI, and Digital in R and D